These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34672171)

  • 1. Radioiodine-refractory thyroid cancer: a complex challenge.
    Vitale G; Pellegrino G; Desiderio E; Barrea L
    Minerva Med; 2021 Dec; 112(6):686-688. PubMed ID: 34672171
    [No Abstract]   [Full Text] [Related]  

  • 2. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
    Janisch A; Altenbrunn HJ; Markwardt J
    Radiobiol Radiother (Berl); 1987; 28(5):707-10. PubMed ID: 3441634
    [No Abstract]   [Full Text] [Related]  

  • 4. TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.
    Yang X; Li J; Li X; Liang Z; Gao W; Liang J; Cheng S; Lin Y
    J Nucl Med; 2017 Feb; 58(2):258-265. PubMed ID: 27493271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of radioiodine in the treatment of local thyroid cancer.
    Tubiana M
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):263-5. PubMed ID: 8823286
    [No Abstract]   [Full Text] [Related]  

  • 6. Depletion regimens for radioiodine therapy of thyroid carcinoma.
    Jackson G
    J Nucl Med; 1985 Aug; 26(8):962. PubMed ID: 4032040
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversy over radioiodine ablation in thyroid cancer: who benefits?
    Yoo DC; Noto RB; Mazzaglia PJ
    Surg Clin North Am; 2014 Jun; 94(3):573-86. PubMed ID: 24857577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy a successful tool in treating thyroid cancer. Foreword.
    Bombardieri E; Pacini F
    Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):439. PubMed ID: 20205316
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted treatments of radio-iodine refractory differentiated thyroid cancer.
    de la Fouchardière C
    Ann Endocrinol (Paris); 2015 Feb; 76(1 Suppl 1):1S34-9. PubMed ID: 26826481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodine and thyroid cancer: some questions, controversies, and considerations.
    Daniels GH
    Endocr Pract; 2001; 7(4):320-3. PubMed ID: 11497485
    [No Abstract]   [Full Text] [Related]  

  • 11. Initial radioiodine administration: when to use it and how to select the dose.
    Esposito G
    Endocrinol Metab Clin North Am; 2014 Jun; 43(2):385-400. PubMed ID: 24891168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.
    Reiners C; Luster M
    Nat Rev Clin Oncol; 2012 Jun; 9(8):432-4. PubMed ID: 22710337
    [No Abstract]   [Full Text] [Related]  

  • 13. Radioiodine in treatment of metastatic thyroid cancer.
    Dewan SS; Sharma SM; Ganatra RD
    Int J Nucl Med Biol; 1979; 6(4):213-4. PubMed ID: 528148
    [No Abstract]   [Full Text] [Related]  

  • 14. Controversies on the Use of Radioiodine in Thyroid Cancer: We Need More and Better Data.
    Pryma DA
    J Nucl Med; 2018 Aug; 59(8):1184-1186. PubMed ID: 29934408
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved planning of radioiodine therapy for thyroid cancer.
    Medvedec M
    J Nucl Med; 2002 May; 43(5):714; author reply 714. PubMed ID: 11994536
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative approach to radioiodine ablation of thyroid remnants following surgery for thyroid cancer.
    Hadjieva T
    Radiobiol Radiother (Berl); 1985; 26(6):819-23. PubMed ID: 4095270
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach.
    Giovanella L; Scappaticcio L
    Q J Nucl Med Mol Imaging; 2019 Sep; 63(3):229-234. PubMed ID: 31271270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutic approaches for metastatic thyroid carcinoma.
    Baudin E; Schlumberger M
    Lancet Oncol; 2007 Feb; 8(2):148-56. PubMed ID: 17267329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Guidelines for radioiodine therapy (RIT) in differentiated thyroid cancer].
    Dietlein M; Dressler J; Farahati J; Leisner B; Moser E; Reiners C; Schicha H; Schober O
    Nuklearmedizin; 1999; 38(6A):221-2. PubMed ID: 10510812
    [No Abstract]   [Full Text] [Related]  

  • 20. [Is radioiodine ablation of residual thyroid tissue indicated after an operation for differentiated thyroid cancer?].
    Chebotareva ED; Shishkina VV
    Lik Sprava; 1997; (1):118-22. PubMed ID: 9221132
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.